Meta-analysis on the efficacy of different blue phototherapy modes on neonatal hyperbilirubinemia

doi:10.11852/zgetbjzz2019-0772

Abstract

Abstract: Objective To evaluate the efficacy and adverse reactions of different blue phototherapy modes on neonatal hyperbilirubinemia,in order to provide scientific evidence for clinical treatment. Methods The clinical randomized controlled study on the treatment of neonatal hyperbilirubinemia by blue phototherapy published from the database inception to May 2018,were retrieved in PubMed,EMBASE,Web of science,Cochrane library,CNKI,VIP and WanFang database. Most literature results were analyzed by RevMan 5.3,but some results were dealt by other medical statistics methods. Results Finally 8 literature containing 954 patients were selected. Meta-analysis showed that phototherapy can significantly decrease the infants′ serum bilirubin level (SMD=55.35,95%CI:50.23-60.48, P<0.001),of which both intermittent phototherapy and continuous phototherapy can also decrease the infants′ serum bilirubin concentration (SMD=58.72,95%CI:54.35～63.09, P<0.001;SMD=51.53,95%CI:41.48～ 61.59, P<0.001). However,the differences on cure rate of neonatal hyperbilirubinemia (χ²=0.00,P=1.00) and the decrease value of the serum bilirubin concentration (SMD=-1.24,95%CI:-5.62-3.15,P=0.58) between different blue phototherapy modes were not significant. Compared with continuous phototherapy,intermittent phototherapy showed lower rate of adverse reactions (RR=0.18,95%CI :0.13-0.25,P<0.001). Conclusions Both intermittent phototherapy and continuous phototherapy can effectively decrease the infants′ serum bilirubin concentration. Meanwhile,the intermittent phototherapy can better reduce the incidence of adverse reactions than continuous phototherapy.

Key words: blue phototherapy, bilirubin, adverse reaction, Meta-analysis

摘要： 目的系统评价不同蓝光治疗模式对新生儿高胆红素血症的疗效及不良反应,为临床治疗提供科学依据。方法检索PubMed、EMBASE、Web of Science、Cochrane library、中国期刊全文数据库(CNKI)、维普中文科技期刊数据库(VIP)、中国生物医学文献数据库(CBM)、万方数据库等数据库中有关蓝光治疗新生儿高胆红素血症临床随机对照研究,检索时限为建库之日起至2018年5月。文献数据统一采用RevMan 5.3 软件进行分析。无法进行Meta分析的指标,则进行相关统计学分析。结果总共纳入8 篇文献,954 例患儿。Meta分析结果显示,蓝光治疗可以降低高胆红素血症患儿的血清胆红素浓度(SMD=55.35, 95%CI:50.23～60.48, P<0.001),差异具有统计学意义。其中间歇性照射治疗后的血清胆红素浓度分析结果为(SMD=58.72,95%CI:54.35～63.09, P<0.001),连续性照射治疗后的血清胆红素浓度分析结果为(SMD=51.53,95%CI:41.48～61.59, P<0.001),差异均具有统计学意义。不同蓝光治疗模式对高胆红素血症患儿的治愈率(χ²=0.00,P=1.00)和血清胆红素浓度的降低程度(SMD=-1.24,95%CI:-5.62～3.15,P=0.58)的差异无统计学意义。与连续性照射治疗相比较,间歇性照射治疗的不良反应发生率更低(RR=0.18,95%CI:0.13～0.25,P<0.001)。结论间歇性与连续性蓝光治疗均能有效的降低高胆红素血症患儿的血清胆红素浓度,其中间歇性照射治疗比连续性照射治疗能够更好的减少患儿不良反应发生。

关键词: 蓝光治疗, 血清胆红素, 不良反应, Meta分析

CLC Number:

R179

SONG Jiu-shan, LUO Cheng, LIANG Kun. Meta-analysis on the efficacy of different blue phototherapy modes on neonatal hyperbilirubinemia[J]. journal1, 2020, 28(3): 299-303.

宋玖珊, 罗程, 梁琨. 不同蓝光治疗模式对新生儿高胆红素血症疗效的Meta分析[J]. 中国儿童保健杂志, 2020, 28(3): 299-303.

References

[1] Hansen TWR.Phototherapy for neonatal jaundice-therape utic effects on more than one level?[J].Semin Perinatol,2010,34(3):231-234.
[2] Kaplan M,Wong RJ,Sibley E.Neonatal jaundice and liver disease[J].Elsevier,2011,20(4):1443-1496.
[3] Scheidt PC,Bryla DA,Nelson KB,et al.Phototherapy for neonatal hyperbilirubinemia:six-year follow-up of the national institute of child health and human development clinical trial[J].Pediatrics,1990,85(4):455-463.
[4] Wickremasinghe AC,Kuzniewicz MW,Grimes BA,et al.Neonatal phototherapy and infantile cancer[J].Pediatrics,2016,137(6):1353-1353.
[5] Amos RC,Jacob H,Leith W,et al.Jaundice in newborn babies under 28 days:NICE guideline 2016 (CG98)[J].Arch Dis Child Educ Pract Ed,2017,102(4):207-209.
[6] Niknafs P,Mortazavi AA,Torabinejad MH,et al.Intermittent versus continuous phototherapy for reducing neonatal hyperbilirubinemia[J].Iranian Journal of Pediatrics,2008,18(3):251-256.
[7] Sachdeva M,Murki S,Oleti TP,et al.Intermittent versus continuous phototherapy for the treatment of neonatal non-hemolytic moderate hyperbilirubinemia in infants more than 34 weeks of gestational age:a randomized controlled trial[J].Eur J Pediatr,2015,174(2):177-181.
[8] Khaliq A.Comparison of continuous with intermittent phototherapy in the treatment of neonatal jaundice[J].JPMI,2016,30(2):1810-1812.
[9] 张亦维.两种光疗方法治疗175例新生儿高未结合胆红素血症的疗效观察[J].重庆医学,2009,38(6):706-706.
[10] 唐红装,梁丽清,谢映梅.短时多次蓝光疗法在新生儿黄疸治疗中的效果观察与护理[J].广东医学,2010,31(23):3154-3155.
[11] 华旭丹.不同方法蓝光照射治疗新生儿高胆红素血症的疗效[J].中国妇幼保健,2012,27(17):2715-2716.
[12] 李罡.间歇性蓝光照射辅助治疗新生儿黄疸临床分析[J].中国妇幼保健,2013,28(23):3777-3779.
[13] 杨春鸿,金晓秋.蓝光间歇辅助治疗新生儿黄疸效果观察[J].中国妇幼保健,2013,28(23):3799-3800.
[14] Maisels MJ,Kring E.The contribution of hemolysis to early jaundice in normal newborns[J].Pediatrics,2006,118(1):276-279.
[15] Burke BL,Robbins JM,Bird TM,et al.,Trends in hospitalizations for neonatal jaundice and kernicterus in the United States,1988-2005[J].Pediatrics,2009,123(2):524-532.
[16] Kuzniewicz MW,Escobar GJ,Newman TB.Impact of universal bilirubin screening on severe hyperbilirubinemia and phototherapy use[J].Pediatrics,2009,124(4):1031-1039.
[17] Maisels MJ,McDonagh AF.Phototherapy for neonatal ja undice[J].N Engl J Med,2008,358(9):920-928.
[18] Podvin D,Kuehn CM,Mueller BA,et al.Maternal and birth characteristics in relation to childhood leukaemia[J].Paediatr Perinat Epidemiol,2006,20(4):312-322.
[19] Cnattingius S,Zack M,Ekbom A,et al.Prenatal and neonatal risk factors for childhood myeloid leukemia[J].Cancer Epidemiol Biomarkers Prev,1995,4(5):441-445.
[20] American Academy of Pediatrics Subcommittee on Hyperbilirubinemia.Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation[J].Pediatrics,2004,114(1):297-316.